Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for delirium in hospitalized general medicine patients
ACTRN12617001537347Phase 3Terminated
- Sponsor
- Alfred Health
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Melatonin with Placebo (2 arms). Primary endpoint: Dose of sedatives used. Started Nov 2017; status: terminated.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12617001537347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001537347.